announcement Tag

PL BioScience Reveals Fall 2025 Conferences Attendance PL BioScience announces participation in upcoming conferences this fall PL BioScience has revealed its participation in six upcoming Fall 2025 conferences. As part of its global strategy, the company will be represented in the following conferences in Asia and Europe:

READ MORE

First Artificial Human Platelet Lysate PL BioScience Raises the Bar in Cell Culture Technology with artificial HPL PL BioScience develops worldwide first artificial Human Platelet Lysate (HPL) solution, and thus a key ingredient for the research & production of cell-based pharmaceuticals. In partnership with the Korean biotech

READ MORE

We are thrilled to unveil our latest innovation: ELAREM™ Ultimate-FD PLUS The gamma irradiated Human Platelet Lysate ELAREM™ Ultimate-FD PLUS is designed to meet the needs of cell manufacturing applications requiring proven viral reduction. As a xeno-free cell culture supplement, ELAREM™ Ultimate-FD PLUS supports the safe and

READ MORE

We are thrilled to announce a significant milestone for PL BioScience! In a recent press release, we reveal that we have successfully closed a €7.8 million Series A financing round. This Series A funding marks a pivotal moment in our company’s growth journey. This substantial infusion

READ MORE
Any questions?
close slider

Any questions?

Please contact us:

support@pl-bioscience.com

+49 (0) 241 95719-100